These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 2144363)

  • 1. Presence of a potent transcription activating sequence in the p53 protein.
    Fields S; Jang SK
    Science; 1990 Aug; 249(4972):1046-9. PubMed ID: 2144363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptional activation by wild-type but not transforming mutants of the p53 anti-oncogene.
    Raycroft L; Wu HY; Lozano G
    Science; 1990 Aug; 249(4972):1049-51. PubMed ID: 2144364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mammalian p53 can function as a transcription factor in yeast.
    Schärer E; Iggo R
    Nucleic Acids Res; 1992 Apr; 20(7):1539-45. PubMed ID: 1579447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for allosteric variants of wild-type p53, a tumour suppressor protein.
    Cook A; Milner J
    Br J Cancer; 1990 Apr; 61(4):548-52. PubMed ID: 2139577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of the two-hybrid system to identify the domain of p53 involved in oligomerization.
    Iwabuchi K; Li B; Bartel P; Fields S
    Oncogene; 1993 Jun; 8(6):1693-6. PubMed ID: 8502489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations in RNA polymerase II enhance or suppress mutations in GAL4.
    Allison LA; Ingles CJ
    Proc Natl Acad Sci U S A; 1989 Apr; 86(8):2794-8. PubMed ID: 2495535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of human colorectal carcinoma cell growth by wild-type p53.
    Baker SJ; Markowitz S; Fearon ER; Willson JK; Vogelstein B
    Science; 1990 Aug; 249(4971):912-5. PubMed ID: 2144057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Separation of DNA binding from the transcription-activating function of a eukaryotic regulatory protein.
    Keegan L; Gill G; Ptashne M
    Science; 1986 Feb; 231(4739):699-704. PubMed ID: 3080805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncogenic forms of p53 inhibit p53-regulated gene expression.
    Kern SE; Pietenpol JA; Thiagalingam S; Seymour A; Kinzler KW; Vogelstein B
    Science; 1992 May; 256(5058):827-30. PubMed ID: 1589764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and characterization of a p53 gene mutation in a human osteosarcoma cell line.
    Romano JW; Ehrhart JC; Duthu A; Kim CM; Appella E; May P
    Oncogene; 1989 Dec; 4(12):1483-8. PubMed ID: 2531855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic analysis of growth inhibition by GAL4-L kappa B-alpha in Saccharomyces cerevisiae.
    Morin PJ; Downs JA; Snodgrass AM; Gilmore TD
    Cell Growth Differ; 1995 Jul; 6(7):789-98. PubMed ID: 7547500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor suppressor genes.
    Levine AJ
    Bioessays; 1990 Feb; 12(2):60-6. PubMed ID: 2140509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53.
    Oliner JD; Pietenpol JA; Thiagalingam S; Gyuris J; Kinzler KW; Vogelstein B
    Nature; 1993 Apr; 362(6423):857-60. PubMed ID: 8479525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IME1 gene encodes a transcription factor which is required to induce meiosis in Saccharomyces cerevisiae.
    Mandel S; Robzyk K; Kassir Y
    Dev Genet; 1994; 15(2):139-47. PubMed ID: 8205723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nucleotide sequence of a cDNA encoding the monkey cellular phosphoprotein p53.
    Rigaudy P; Eckhart W
    Nucleic Acids Res; 1989 Oct; 17(20):8375. PubMed ID: 2530498
    [No Abstract]   [Full Text] [Related]  

  • 16. The neuroendocrine protein 7B2 contains unusually potent transcriptional activating sequences.
    Chaudhuri B; Huijbregts RP; Coen JJ; Fürst P
    Biochem Biophys Res Commun; 1995 Nov; 216(1):1-10. PubMed ID: 7488073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53 interacts with p34cdc2 in mammalian cells: implications for cell cycle control and oncogenesis.
    Stürzbecher HW; Maimets T; Chumakov P; Brain R; Addison C; Simanis V; Rudge K; Philp R; Grimaldi M; Court W
    Oncogene; 1990 Jun; 5(6):795-81. PubMed ID: 2141683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of transactivation and transrepression function, and not RPA binding, alters growth suppression by p53.
    Leiter LM; Chen J; Marathe T; Tanaka M; Dutta A
    Oncogene; 1996 Jun; 12(12):2661-8. PubMed ID: 8700525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Negative growth regulation in a glioblastoma tumor cell line that conditionally expresses human wild-type p53.
    Mercer WE; Shields MT; Amin M; Sauve GJ; Appella E; Romano JW; Ullrich SJ
    Proc Natl Acad Sci U S A; 1990 Aug; 87(16):6166-70. PubMed ID: 2143581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The protein encoded by oncogene 6b from Agrobacterium tumefaciens interacts with a nuclear protein of tobacco.
    Kitakura S; Fujita T; Ueno Y; Terakura S; Wabiko H; Machida Y
    Plant Cell; 2002 Feb; 14(2):451-63. PubMed ID: 11884686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.